1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic and Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars/follow-on-biologics Market Perspective (2017-2028)
2.2 Biosimilars/follow-on-biologics Growth Trends by Region
2.2.1 Biosimilars/follow-on-biologics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biosimilars/follow-on-biologics Historic Market Size by Region (2017-2022)
2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Region (2023-2028)
2.3 Biosimilars/follow-on-biologics Market Dynamics
2.3.1 Biosimilars/follow-on-biologics Industry Trends
2.3.2 Biosimilars/follow-on-biologics Market Drivers
2.3.3 Biosimilars/follow-on-biologics Market Challenges
2.3.4 Biosimilars/follow-on-biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars/follow-on-biologics Players by Revenue
3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2017-2022)
3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2017-2022)
3.2 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue
3.4 Global Biosimilars/follow-on-biologics Market Concentration Ratio
3.4.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2021
3.5 Biosimilars/follow-on-biologics Key Players Head office and Area Served
3.6 Key Players Biosimilars/follow-on-biologics Product Solution and Service
3.7 Date of Enter into Biosimilars/follow-on-biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilars/follow-on-biologics Breakdown Data by Type
4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2017-2022)
4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2023-2028)
5 Biosimilars/follow-on-biologics Breakdown Data by Application
5.1 Global Biosimilars/follow-on-biologics Historic Market Size by Application (2017-2022)
5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biosimilars/follow-on-biologics Market Size (2017-2028)
6.2 North America Biosimilars/follow-on-biologics Market Size by Type
6.2.1 North America Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
6.2.2 North America Biosimilars/follow-on-biologics Market Size by Type (2023-2028)
6.2.3 North America Biosimilars/follow-on-biologics Market Share by Type (2017-2028)
6.3 North America Biosimilars/follow-on-biologics Market Size by Application
6.3.1 North America Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
6.3.2 North America Biosimilars/follow-on-biologics Market Size by Application (2023-2028)
6.3.3 North America Biosimilars/follow-on-biologics Market Share by Application (2017-2028)
6.4 North America Biosimilars/follow-on-biologics Market Size by Country
6.4.1 North America Biosimilars/follow-on-biologics Market Size by Country (2017-2022)
6.4.2 North America Biosimilars/follow-on-biologics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biosimilars/follow-on-biologics Market Size (2017-2028)
7.2 Europe Biosimilars/follow-on-biologics Market Size by Type
7.2.1 Europe Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
7.2.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2023-2028)
7.2.3 Europe Biosimilars/follow-on-biologics Market Share by Type (2017-2028)
7.3 Europe Biosimilars/follow-on-biologics Market Size by Application
7.3.1 Europe Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
7.3.2 Europe Biosimilars/follow-on-biologics Market Size by Application (2023-2028)
7.3.3 Europe Biosimilars/follow-on-biologics Market Share by Application (2017-2028)
7.4 Europe Biosimilars/follow-on-biologics Market Size by Country
7.4.1 Europe Biosimilars/follow-on-biologics Market Size by Country (2017-2022)
7.4.2 Europe Biosimilars/follow-on-biologics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size (2017-2028)
8.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type
8.2.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biosimilars/follow-on-biologics Market Share by Type (2017-2028)
8.3 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application
8.3.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biosimilars/follow-on-biologics Market Share by Application (2017-2028)
8.4 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region
8.4.1 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biosimilars/follow-on-biologics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosimilars/follow-on-biologics Market Size (2017-2028)
9.2 Latin America Biosimilars/follow-on-biologics Market Size by Type
9.2.1 Latin America Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
9.2.2 Latin America Biosimilars/follow-on-biologics Market Size by Type (2023-2028)
9.2.3 Latin America Biosimilars/follow-on-biologics Market Share by Type (2017-2028)
9.3 Latin America Biosimilars/follow-on-biologics Market Size by Application
9.3.1 Latin America Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
9.3.2 Latin America Biosimilars/follow-on-biologics Market Size by Application (2023-2028)
9.3.3 Latin America Biosimilars/follow-on-biologics Market Share by Application (2017-2028)
9.4 Latin America Biosimilars/follow-on-biologics Market Size by Country
9.4.1 Latin America Biosimilars/follow-on-biologics Market Size by Country (2017-2022)
9.4.2 Latin America Biosimilars/follow-on-biologics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size (2017-2028)
10.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type
10.2.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biosimilars/follow-on-biologics Market Share by Type (2017-2028)
10.3 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application
10.3.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biosimilars/follow-on-biologics Market Share by Application (2017-2028)
10.4 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country
10.4.1 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biosimilars/follow-on-biologics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis (Sandoz)
11.1.1 Novartis (Sandoz) Company Details
11.1.2 Novartis (Sandoz) Business Overview
11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction
11.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.1.5 Novartis (Sandoz) Recent Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.2.5 Synthon Pharmaceuticals Recent Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.3.5 Teva Pharmaceutical Industries Recent Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction
11.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.4.5 LG Life Sciences Recent Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Details
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction
11.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.5.5 Celltrion Biocon Recent Developments
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Biosimilars/follow-on-biologics Introduction
11.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.6.5 Hospira Recent Developments
11.7 Merck Serono (Merck)
11.7.1 Merck Serono (Merck) Company Details
11.7.2 Merck Serono (Merck) Business Overview
11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction
11.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.7.5 Merck Serono (Merck) Recent Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Details
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction
11.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.8.5 Biogen idec Recent Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction
11.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2017-2022)
11.9.5 Genentech (Roche) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Human growth hormone
Table 3. Key Players of Erythropoietin
Table 4. Key Players of Monoclonal antibodies
Table 5. Key Players of Insulin
Table 6. Key Players of Interferon
Table 7. Key Players of Granulocyte-Colony Stimulating Factor
Table 8. Key Players of Others
Table 9. Global Biosimilars/follow-on-biologics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Biosimilars/follow-on-biologics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Biosimilars/follow-on-biologics Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Biosimilars/follow-on-biologics Market Share by Region (2017-2022)
Table 13. Global Biosimilars/follow-on-biologics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Biosimilars/follow-on-biologics Market Share by Region (2023-2028)
Table 15. Biosimilars/follow-on-biologics Market Trends
Table 16. Biosimilars/follow-on-biologics Market Drivers
Table 17. Biosimilars/follow-on-biologics Market Challenges
Table 18. Biosimilars/follow-on-biologics Market Restraints
Table 19. Global Biosimilars/follow-on-biologics Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Biosimilars/follow-on-biologics Revenue Share by Players (2017-2022)
Table 21. Global Top Biosimilars/follow-on-biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars/follow-on-biologics as of 2021)
Table 22. Ranking of Global Top Biosimilars/follow-on-biologics Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Biosimilars/follow-on-biologics Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biosimilars/follow-on-biologics Product Solution and Service
Table 26. Date of Enter into Biosimilars/follow-on-biologics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2017-2022)
Table 30. Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2023-2028)
Table 32. Global Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Biosimilars/follow-on-biologics Revenue Share by Application (2017-2022)
Table 34. Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Biosimilars/follow-on-biologics Revenue Share by Application (2023-2028)
Table 36. North America Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Biosimilars/follow-on-biologics Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Biosimilars/follow-on-biologics Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Biosimilars/follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Biosimilars/follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Biosimilars/follow-on-biologics Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Biosimilars/follow-on-biologics Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Biosimilars/follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Biosimilars/follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Biosimilars/follow-on-biologics Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Biosimilars/follow-on-biologics Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Biosimilars/follow-on-biologics Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Biosimilars/follow-on-biologics Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Biosimilars/follow-on-biologics Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Biosimilars/follow-on-biologics Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Biosimilars/follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Biosimilars/follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Biosimilars/follow-on-biologics Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Biosimilars/follow-on-biologics Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Biosimilars/follow-on-biologics Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Biosimilars/follow-on-biologics Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Biosimilars/follow-on-biologics Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Biosimilars/follow-on-biologics Market Size by Country (2023-2028) & (US$ Million)
Table 66. Novartis (Sandoz) Company Details
Table 67. Novartis (Sandoz) Business Overview
Table 68. Novartis (Sandoz) Biosimilars/follow-on-biologics Product
Table 69. Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 70. Novartis (Sandoz) Recent Developments
Table 71. Synthon Pharmaceuticals Company Details
Table 72. Synthon Pharmaceuticals Business Overview
Table 73. Synthon Pharmaceuticals Biosimilars/follow-on-biologics Product
Table 74. Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 75. Synthon Pharmaceuticals Recent Developments
Table 76. Teva Pharmaceutical Industries Company Details
Table 77. Teva Pharmaceutical Industries Business Overview
Table 78. Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Product
Table 79. Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 80. Teva Pharmaceutical Industries Recent Developments
Table 81. LG Life Sciences Company Details
Table 82. LG Life Sciences Business Overview
Table 83. LG Life Sciences Biosimilars/follow-on-biologics Product
Table 84. LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 85. LG Life Sciences Recent Developments
Table 86. Celltrion Biocon Company Details
Table 87. Celltrion Biocon Business Overview
Table 88. Celltrion Biocon Biosimilars/follow-on-biologics Product
Table 89. Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 90. Celltrion Biocon Recent Developments
Table 91. Hospira Company Details
Table 92. Hospira Business Overview
Table 93. Hospira Biosimilars/follow-on-biologics Product
Table 94. Hospira Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 95. Hospira Recent Developments
Table 96. Merck Serono (Merck) Company Details
Table 97. Merck Serono (Merck) Business Overview
Table 98. Merck Serono (Merck) Biosimilars/follow-on-biologics Product
Table 99. Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 100. Merck Serono (Merck) Recent Developments
Table 101. Biogen idec Company Details
Table 102. Biogen idec Business Overview
Table 103. Biogen idec Biosimilars/follow-on-biologics Product
Table 104. Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 105. Biogen idec Recent Developments
Table 106. Genentech (Roche) Company Details
Table 107. Genentech (Roche) Business Overview
Table 108. Genentech (Roche) Biosimilars/follow-on-biologics Product
Table 109. Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2017-2022) & (US$ Million)
Table 110. Genentech (Roche) Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilars/follow-on-biologics Market Share by Type: 2021 VS 2028
Figure 2. Human growth hormone Features
Figure 3. Erythropoietin Features
Figure 4. Monoclonal antibodies Features
Figure 5. Insulin Features
Figure 6. Interferon Features
Figure 7. Granulocyte-Colony Stimulating Factor Features
Figure 8. Others Features
Figure 9. Global Biosimilars/follow-on-biologics Market Share by Application: 2021 VS 2028
Figure 10. Blood Disorders Case Studies
Figure 11. Oncology Diseases Case Studies
Figure 12. Chronic and Autoimmune Diseases Case Studies
Figure 13. Growth Hormone Deficiencies Case Studies
Figure 14. Others Case Studies
Figure 15. Biosimilars/follow-on-biologics Report Years Considered
Figure 16. Global Biosimilars/follow-on-biologics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Biosimilars/follow-on-biologics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Biosimilars/follow-on-biologics Market Share by Region: 2021 VS 2028
Figure 19. Global Biosimilars/follow-on-biologics Market Share by Players in 2021
Figure 20. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars/follow-on-biologics as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2021
Figure 22. North America Biosimilars/follow-on-biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. North America Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2028)
Figure 24. North America Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2028)
Figure 25. North America Biosimilars/follow-on-biologics Market Size Share by Country (2017-2028)
Figure 26. United States Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Canada Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Europe Biosimilars/follow-on-biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 29. Europe Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2028)
Figure 30. Europe Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2028)
Figure 31. Europe Biosimilars/follow-on-biologics Market Size Share by Country (2017-2028)
Figure 32. Germany Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Biosimilars/follow-on-biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 39. Asia Pacific Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2028)
Figure 40. Asia Pacific Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2028)
Figure 41. Asia Pacific Biosimilars/follow-on-biologics Market Size Share by Region (2017-2028)
Figure 42. China Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Japan Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. South Korea Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Southeast Asia Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. India Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Australia Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 48. Latin America Biosimilars/follow-on-biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Latin America Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2028)
Figure 50. Latin America Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2028)
Figure 51. Latin America Biosimilars/follow-on-biologics Market Size Share by Country (2017-2028)
Figure 52. Mexico Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Brazil Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Middle East & Africa Biosimilars/follow-on-biologics Market Size YoY (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Biosimilars/follow-on-biologics Market Size Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Biosimilars/follow-on-biologics Market Size Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Biosimilars/follow-on-biologics Market Size Share by Country (2017-2028)
Figure 58. Turkey Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. UAE Biosimilars/follow-on-biologics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 61. Novartis (Sandoz) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 62. Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 63. Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 64. LG Life Sciences Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 65. Celltrion Biocon Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 66. Hospira Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 67. Merck Serono (Merck) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 68. Biogen idec Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 69. Genentech (Roche) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
